Time to change diagnostic criteria of ARDS: Toward the disease entity-based subgrouping

Pulmonary Pharmacology and Therapeutics

Volumn 18, Issue 2, 2005, Pages 115-119

  Takeda, Shinhiro ^a   Ishizaka, Akitoshi ^b   Fujino, Yuji ^c   Fukuoka, Toshio ^d   Nagano, Osamu ^e   Yamada, Yoshitsugu ^f   Takezawa, Jun ^d  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY HOSPITAL   (Japan)

^d NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e OKAYAMA UNIVERSITY HOSPITAL   (Japan)

^f YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

AECC; Mortality; Patient characteristics; RCTs; Sepsis

Indexed keywords

ALBUMIN; FUROSEMIDE; KETOCONAZOLE; LISOFYLLINE; METHYLPREDNISOLONE; NITRIC OXIDE; PROSTAGLANDIN E1; SURFACTANT;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; ARTIFICIAL VENTILATION; BODY POSTURE; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; DISEASE SEVERITY; HUMAN; MORBIDITY; MORTALITY; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SURVIVAL; TREATMENT OUTCOME;

HUMANS; RANDOMIZED CONTROLLED TRIALS; RESPIRATORY DISTRESS SYNDROME, ADULT; SEVERITY OF ILLNESS INDEX;

EID: 11844263932     PISSN: 10945539     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pupt.2004.11.001     Document Type: Article

References (46)

1. E. Abraham, M.A. Matthay, C.A. Dinarello, J.L. Vincent, J. Cohen, and S.M. Opal Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: time for a reevaluation Crit Care Med 28 2000 232 235
2. Multicenter clinical trial committee, Japan Society of Respiratory Care Medicine Clinical practice guideline for ARDS Jpn J Respir Care 16 1999 95 115 [in Japanese]
3. G.R. Bernard, A. Artigas, K.L. Brigham, J. Carlet, K. Falke, and L. Hudson The American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination Am J Respir Crit Care Med 149 1994 818 824
4. D.G. Ashbaugh, D.B. Bigelow, T.L. Petty, and B.E. Levine Acute respiratory distress in adults Lancet 2 1967 319 323
5. T.L. Petty Adult respiratory distress syndrome: definition and historical perspective Clin Chest Med 3 1982 3 7
6. G.D. Rubenfeld Epidemiology of acute lung injury Crit Care Med 31 2003 S276 S284
7. M.D. Zilberberg, and S.K. Epstein Acute lung injury in the medical ICU: comorbid conditions, age, etiology, and hospital outcome Am J Respir Crit Care Med 157 1998 1159 1164
8. P. Krafft, P. Fridrich, T. Pernerstorfer, R.D. Fitzgerald, D. Koc, and B. Schneider The acute respiratory distress syndrome: definitions, severity and clinical outcome. An analysis of 101 clinical investigations Intens Care Med 22 1996 519 529
9. R.C. Bone, G. Slotman, R. Maunder, H. Silverman, T.M. Hyers, and M.D. Kerstein Randomized double-blind, multicenter study of prostaglandin E1 in patients with the adult respiratory distress syndrome. Prostaglandin E1 Study Group Chest 96 1989 114 119
10. F. Frutos-Vivar, N. Nin, and A. Esteban Epidemiology of acute lung injury and acute respiratory distress syndrome Curr Opin Crit Care 10 2004 1 6
11. A.N. Chesnutt, M.A. Matthay, F. Tibayan, and J.G. Clark Early detection of type III procollagen peptide in acute lung injury: pathogenetic and prognostic significance Am J Respir Crit Care Med 156 1997 840 845
12. D.B. Rubin, J.P. Wiener-Kronish, J.F. Murray, D.R. Green, J. Turner, and J.M. Luce Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome J Clin Invest 86 1990 474 480
13. R.L. Doyle, N. Szaflarski, G.W. Modin, J.P. Wiener-Kronish, and M.A. Matthay Identification of patients with acute lung injury: predictors of mortality Am J Respir Crit Care Med 152 1995 1818 1824
14. Australian and New Zealand Intensive Care Society Clinical Trials Group A.D. Bersten, C. Edibam, T. Hunt, and J. Moran Incidence and mortality of acute lung injury and the acute respiratory distress syndrome in three Australian states Am J Respir Crit Care Med 165 2002 443 448
15. A.B. Montgomery, M.A. Stager, C.J. Carrico, and L.D. Hudson Causes of mortality in patients with the adult respiratory distress syndrome Am Rev Respir Dis 132 1985 485 489
16. M. Ferring, and J.L. Vincent Is outcome from ARDS related to the severity of respiratory failure? Eur Respir J 10 1997 1297 1300
17. L.D. Hudson, J.A. Milberg, D. Anardi, and R.J. Maunder Clinical risks for development of the acute respiratory distress syndrome Am J Respir Crit Care Med 151 1995 293 301
18. The ARDS Clinical Trials Network Randomized, placebo-controlled trial of lisofylline for early treatment of acute lung injury and acute respiratory distress syndrome Crit Care Med 30 2002 1 6
19. A.C. Arroliga, Z.W. Ghamra, A. Pérez-Trepichio, P. Pérez-Trepichio, J.J. Komara Jr, A. Smith, and H.P. Wiedemann Incidence of ARDS in an adult population of Northeast Ohio Chest 121 2002 1972 1976
20. A.F. Shorr, K.C. Abbott, and L.Y. Agadoa Acute respiratory distress syndrome after kidney transplantation: epidemiology, risk factors, and outcomes Crit Care Med 31 2003 1325 1330
21. C.C. Silliman, L.K. Boshkov, Z. Mehdizadehkashi, D.J. Elzi, W.O. Dickey, and L. Podlosky Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors Blood 101 2003 454 462
22. H.G. Folkesson, M.A. Matthay, C.A. Hebert, and V.C. Broaddus Acid aspiration-induced lung injury in rabbits is mediated by interleukin-8 dependent mechanisms J Clin Invest 96 1995 107 116
23. J.F. Pittet, R.C. Mackersie, T.R. Martin, and M.A. Matthay Biological markers of acute lung injury: prognostic and pathogenetic significance Am J Respir Crit Care Med 155 1997 1187 1205
24. J.P. Wiener-Kronish, T. Sakuma, I. Kudoh, J.F. Pittet, D. Frank, and L. Dobbs Alveolar epithelial injury and pleural empyema in acute P. aeruginosa pneumonia in anesthetized rabbits J Appl Physiol 75 1993 1661 1669
25. M. Moss, M.K. Gillespie, L. Ackerson, F.A. Moore, E.E. Moore, and P.E. Parsons Endothelial cell activity varies in patients at risk for the adult respiratory distress syndrome Crit Care Med 24 1996 1782 1786
26. P.E. Parsons, G.S. Worthen, E.E. Moore, R.M. Tate, and P.M. Henson The association of circulating endotoxin with the development of the adult respiratory distress syndrome Am Rev Respir Dis 140 1989 294 301
27. T.J. Donnelly, P. Meade, M. Jagels, H.G. Cryer, M.M. Law, and T.E. Hugli Cytokine, complement and endotoxin profiles associated with the development of the adult respiratory distress syndrome after severe injury Crit Care Med 22 1994 768 776
28. J.G. Clark, J.A. Milberg, K.P. Steinberg, L.D. Hudson, and. Type III procollagen peptide in the adult respiratory distress syndrome. Association of increased peptide levels in bronchoalveolar lavage fluid with increased risk for death Ann Intern Med 122 1995 17 23
29. K.P. Steinberg, J.A. Milberg, T.R. Martin, R.J. Maunder, B.A. Cockrill, and L.D. Hudson Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome Am J Respir Crit Care Med 150 1994 113 122
30. R.P. Baughman, K.L. Gunther, M.C. Rashkin, D.A. Keeton, and E.N. Pattishall Changes in the inflammatory response of the lung during acute respiratory distress syndrome: prognostic indicators Am J Respir Crit Care Med 154 1996 76 81
31. A. Anzueto, R.P. Baughman, K.K. Guntupalli, J.G. Weg, H.P. Wiedemann, A.A. Raventos, F. Lemaire, W. Long, D.S. Zaccardelli, and E.N. Pattishall Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group N Engl J Med 334 1996 1417 1421
32. R.P. Dellinger, J.L. Zimmerman, R.W. Taylor, R.C. Straube, D.L. Hauser, and G.J. Criner Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group Crit Care Med 26 1998 15 23
33. G.U. Meduri, A.S. Headley, E. Golden, S.J. Carson, R.A. Umberger, and T. Kelso Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial JAMA 280 1998 159 165
34. E. Abraham, R. Baughman, E. Fletcher, S. Heard, J. Lamberti, H. Levy, L. Nelson, M. Rumbak, J. Steingrub, J. Taylor, Y.C. Park, J.M. Hynds, and J. Freitag Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndrome: a controlled, randomized, double-blind, multicenter clinical trial. TLC C-53 ARDS Study Group Crit Care Med 27 1999 1478 1485
35. R.G. Brower, C.B. Shanholtz, H.E. Fessler, D.M. Shade, P. White Jr, C.M. Wiener, J.G. Teeter, J.M. Dodd-o, Y. Almog, and S. Piantadosi Prospective, randomized, controlled clinical trial comparing traditional versus reduced tidal volume ventilation in acute respiratory distress syndrome patients Crit Care Med 27 1999 1492 1498
36. A. Esteban, I. Alia, F. Gordo, R. de Pablo, J. Suarez, G. Gonzalez, and J. Blanco Prospective randomized trial comparing pressure-controlled ventilation and volume-controlled ventilation in ARDS. For the Spanish Lung Failure Collaborative Group Chest 117 2000 1690 1696
37. The ARDS Network Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome N Engl J Med 342 2000 1301 1308
38. The ARDS Network Ketoconazole for early treatment of acute lung injury and acute respiratory distress syndrome: a randomized controlled trial JAMA 283 2000 1995 2002
39. J.L. Vincent, R. Brase, F. Santman, P.M. Suter, A. McLuckie, and J.F. Dhainaut A multi-centre, double-blind, placebo-controlled study of liposomal prostaglandin E1 (TLC C-53) in patients with acute respiratory distress syndrome Intens Care Med 27 2001 1578 1583
40. L. Gattinoni, G. Tognoni, A. Pesenti, P. Taccone, D. Mascheroni, and V. Labarta Prone-Supine Study Group. Effect of prone positioning on the survival of patients with acute respiratory failure N Engl J Med 345 2001 568 573
41. G.S. Martin, R.J. Mangialardi, A.P. Wheeler, W.D. Dupont, J.A. Morris, and G.R. Bernard Albumin and furosemide therapy in hypoproteinemic patients with acute lung injury Crit Care Med 30 2002 2175 2182
42. S. Derdak, S. Mehta, T.E. Stewart, T. Smith, M. Rogers, and T.G. Buchman Multicenter Oscillatory Ventilation For Acute Respiratory Distress Syndrome Trial (MOAT) Study Investigators. High-frequency oscillatory ventilation for acute respiratory distress syndrome in adults: a randomized, controlled trial Am J Respir Crit Care Med 166 2002 801 808
43. M.A. Jantz, and S.A. Sahn Corticosteroids in acute respiratory failure Am J Respir Crit Care Med 160 1999 1079 1100
44. M. Yu, and G. Tomasa A double-blind, prospective, randomized trial of ketoconazole, a thromboxane synthetase inhibitor, in the prophylaxis of the adult respiratory distress syndrome Crit Care Med 21 1993 1635 1642
45. G.J. Slotman, K.W. Burchard, A. D'Arezzo, and D.S. Gann Ketoconazole prevents acute respiratory failure in critically ill surgical patients J Trauma 28 1988 648 654
46. L.D. Hudson, and K.P. Steinberg Epidemiology of acute lung injury and ARDS Chest 116 1999 74S 88S